PT624. Clinical profiles of obsessive compulsive symptoms in schizophrenic patients
نویسنده
چکیده
s | 29 Abstract Background: Preliminary results have supported the use of D-cycloserine (DCS), a partial agonist at theN-methyl-D-aspartate receptor in the amygdala,to augment exposure therapy in adult anxiety disorders; however, no data have been provided a quantitative review of DCS-augmented cognitive behavioral therapy literature. Objectives: To investigate the effect of DCS enhances the overall efficacy of cognitive-behavioral therapy (CBT) inthe treatment of obsessive-compulsive disorder (OCD). Methods: Medline/Pubmed, OVID,and the Cochrane central register of controlled trialswere searched through to May 2015. Five of the 338 articles (n = 119 participants) initiallyidentified met the inclusion criteria, reporting 5 randomized controlled trials. Results: Compliance with homogeneity, effect of each literature can be combined using a fixed effect model (Chi2=2.97, i2=0%, p=0.56). The confidence interval of most studies crossesthe vertical line of null effect (mean difference equal to zero),indicating that the majority of these studies did not find astatistically significant difference between DCS+CBT and placebo+CBT. Conclusions: D-cycloserine has a neutral effect on enhancingcognitive-behavioral therapy in the treatment of obsessive compulsive disorder in randomized controlled trials. The present results fail to support the use of D-cycloserine with cognitive behavioral therapy for obsessive compulsive disorder.Background: Preliminary results have supported the use of D-cycloserine (DCS), a partial agonist at theN-methyl-D-aspartate receptor in the amygdala,to augment exposure therapy in adult anxiety disorders; however, no data have been provided a quantitative review of DCS-augmented cognitive behavioral therapy literature. Objectives: To investigate the effect of DCS enhances the overall efficacy of cognitive-behavioral therapy (CBT) inthe treatment of obsessive-compulsive disorder (OCD). Methods: Medline/Pubmed, OVID,and the Cochrane central register of controlled trialswere searched through to May 2015. Five of the 338 articles (n = 119 participants) initiallyidentified met the inclusion criteria, reporting 5 randomized controlled trials. Results: Compliance with homogeneity, effect of each literature can be combined using a fixed effect model (Chi2=2.97, i2=0%, p=0.56). The confidence interval of most studies crossesthe vertical line of null effect (mean difference equal to zero),indicating that the majority of these studies did not find astatistically significant difference between DCS+CBT and placebo+CBT. Conclusions: D-cycloserine has a neutral effect on enhancingcognitive-behavioral therapy in the treatment of obsessive compulsive disorder in randomized controlled trials. The present results fail to support the use of D-cycloserine with cognitive behavioral therapy for obsessive compulsive disorder. PT624 Clinical profiles of obsessive compulsive symptoms in schizophrenic patients Min-Seong Koo, Kwandong University School of Medicine, Republic of
منابع مشابه
Obsessive-Compulsive Disorder in Hospitalized Patients with Schizophrenia
Introduction: Comorbid obsessive-compulsive disorder (OCD) has been reported among patients with schizophrenia in other countries. But, the literature is not well-documented on this issue in Iran (Persia). The present study aimed to investigate the prevalence and severity of OCD and some of its related factors in a group of patients with schizophrenia in Iran. Methods: This is a cross-se...
متن کامل[Comparison of patients with schizophrenia, obsessive-compulsive disorder, and schizophrenia with accompanying obsessive-compulsive symptoms].
OBJECTIVE The present study aimed to determine if schizophrenic patients with OC-symptoms represent a subtype of schizophrenia and to evaluate the differences between schizophrenic patients with OC symptoms and OCD patients. METHODS The study included 20 patients diagnosed with OCD, 40 schizophrenic patients, and 20 schizophrenic patients with OC symptoms. While the distribution and the sever...
متن کاملThe Effectiveness of Cognitive Analytic Therapy on the Severity of Symptoms in Patients with Obsessive-Compulsive Disorder
Objective: Obsessive-compulsive disorder at clinical levels has elevated symptoms that result in deteriorated psycho-social functions. This study was aimed to examine the effectiveness of cognitive analytic therapy on symptoms severity of obsessive-compulsive disorder. Methods: This exploratory empirical study was a clinical trial that used quasi-experimental design to systemically investiga...
متن کاملAripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
OBJECTIVE Patients with schizophrenia often experience comorbid obsessive-compulsive symptoms. Within these patients, a significant subgroup developed secondary obsessive-compulsive symptoms during treatment with clozapine. METHOD In this paper, we report on four cases in which adjunctive therapy with aripiprazole was tested to alleviate obsessive-compulsive symptoms in schizophrenia. RESUL...
متن کاملCognitive event-related potentials differentiate schizophrenia with obsessive-compulsive disorder (schizo-OCD) from OCD and schizophrenia without OC symptoms.
Clinical and neurobiological evidence suggests that concurrent presentation of schizophrenia and obsessive-compulsive (schizo-OCD) symptoms represents a distinct clinical entity. Given that obsessive-compulsive disorder (OCD) and schizophrenia have been modeled as having different neurofunctional profiles, the overlap between them represents a heuristic challenge for cognitive and endophenotype...
متن کامل